文献速递血管炎

PET/CT在大血管炎疾病活动度评估中的作用

The role of PET/CT in disease activity assessment in patients with large vessel vasculitis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该单中心回顾性队列研究纳入100例大血管炎患者(51例大血管型巨细胞动脉炎、49例大动脉炎),共476次PET/CT扫描,评估PET/CT视觉分级和PETVAS评分判断疾病活动度的准确性及预测复发的能力。结果显示视觉分级和PETVAS区分临床活动与缓解的准确性中等(AUC分别为0.70和0.73),PETVAS未能预测后续复发。

要点

  • PET/CT视觉分级区分临床活动与缓解的敏感度60%、特异度80.1%,AUC 0.70。
  • PETVAS≥10区分活动与缓解的敏感度60.8%、特异度80.6%,AUC 0.73。
  • PETVAS与后续复发无关,年龄性别校正HR 1.04(95%CI 0.97, 1.11)。

核心结论

  • PET/CT视觉分级量表与PETVAS区分活动性大血管炎与缓解的准确性为中等,PETVAS未能预测疾病复发。

研究设计与样本

  • 单中心回顾性队列研究,分析2007年至2020年前瞻性收集的连续确诊大血管炎患者数据,纳入至少接受一次PET/CT扫描者。
  • 共纳入100例连续大血管炎患者(51例大血管型巨细胞动脉炎、49例大动脉炎),共完成476次PET/CT扫描,平均随访97.5个月。

主要发现

  • 医师判定的PET/CT分级区分临床活动与不活动大血管炎的敏感度为60%(95%CI 50.9, 68.7),特异度为80.1%(95%CI 75.5, 84.1),AUC为0.70(95%CI 0.65, 0.75)。
  • PETVAS与疾病活动相关,年龄和性别校正后活动性疾病的OR为1.15(95%CI 1.11, 1.19)。
  • PETVAS≥10区分临床活动与不活动大血管炎的敏感度为60.8%,特异度为80.6%,AUC为0.73(95%CI 0.68, 0.79)。
  • PETVAS与后续复发无关,年龄和性别校正后HR为1.04(95%CI 0.97, 1.11)。

关键数值与推荐

  • 医师判定的PET/CT分级(活动/不活动血管炎)与疾病活动临床判断(活动期/缓解期)比较,敏感度60%(95%CI 50.9, 68.7),特异度80.1%(95%CI 75.5, 84.1),AUC 0.70(95%CI 0.65, 0.75)。
  • PETVAS评估疾病活动度的年龄和性别校正OR为1.15(95%CI 1.11, 1.19)。
  • PETVAS≥10区分临床活动与不活动大血管炎的敏感度60.8%、特异度80.6%,AUC 0.73(95%CI 0.68, 0.79)。
  • PETVAS预测后续复发的年龄和性别校正HR为1.04(95%CI 0.97, 1.11)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the accuracy of PET/CT and of PET vascular activity score (PETVAS) in assessing disease activity and the ability of PETVAS in predicting relapses in a large single-centre cohort of patients with large vessel vasculitis (LVV). METHODS: We conducted a retrospective cohort study of prospectively collected data of consecutive patients diagnosed with LVV who underwent at least one PET/CT scan between 2007 and 2020. The nuclear medicine physician's interpretation of each PET/CT scan (active/inactive vasculitis) was compared with disease activity clinical judgement (active disease/remission). For each PET/CT scan, the PETVAS score was calculated and its accuracy in assessing disease activity was evaluated. The ability of PETVAS in predicting subsequent relapses was evaluated. RESULTS: A total of 100 consecutive LVV patients (51 large vessel GCA, 49 Takayasu arteritis) underwent a total of 476 PET/CT scans over a mean follow-up period of 97.5 months. Physician-determined PET/CT grading was able to distinguish between clinically active and inactive LVV with a sensitivity of 60% (95% CI 50.9, 68.7) and specificity of 80.1% (95% CI 75.5, 84.1); the area under the curve (AUC )was 0.70 (95% CI 0.65, 0.75). PETVAS was associated with disease activity, with an age and sex-adjusted odds ratio for active disease of 1.15 (95% CI 1.11, 1.19). A PETVAS ≥10 provided 60.8% sensitivity and 80.6% specificity in differentiating between clinically active and inactive LVV; the AUC was 0.73 (95% CI 0.68, 0.79). PETVAS was not associated with subsequent relapses, with an age and sex-adjusted hazard ratio of 1.04 (95% CI 0.97, 1.11). CONCLUSIONS: The visual PET/CT grading scale and PETVAS had moderate accuracy to distinguish active LVV from remission. PETVAS did not predict disease relapses.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Galli E, Muratore F, Mancuso P, et al. The role of PET/CT in disease activity assessment in patients with large vessel vasculitis. Rheumatology (Oxford). 2022. PMID: 35258570. doi:10.1093/rheumatology/keac125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。